Table 2.
Percentage of reduction in heat (J) produced by MRSA and MSSA biofilms treated with the different tested antibiotics.
| MRSA |
MSSA |
|||||
|---|---|---|---|---|---|---|
| Antibiotic | ≥25% | ≥50% | ≥75% | ≥25% | ≥50% | ≥75% |
| DAP | 16 | 32 | 32 | 32 | 32 | 32 |
| FOS | 256 | – | – | 1024 | 1024 | – |
| VAN | 256 | 1024 | – | 1024 | – | – |
| TMP/SXT | 128 | – | – | – | – | – |
| LZD | 32 | 1024 | – | – | – | – |
| RIF | 32 | 128 | 128 | 128 | 256 | 256 |
Daptomycin (DAP), fosfomycin (FOS), vancomycin (VAN), trimethoprim/sulfamethoxazole (TMP/SXT), linezolid (LNZ), and rifampicin (RIF). Numbers in bold represent the MBBCs and concentrations are expressed in μg/ml. TMP/SXT concentrations are expressed as trimethoprim concentrations. n.t., not tested.